Intriguingly, the loss of REST in leiomyomas was not associated with enhanced β–TrCP mediated ubiquitin-proteasomal degradation of REST9, suggesting that a novel mechanism may exist for its loss in leiomyomas. The gene discussed is REST; the disease is leiomyoma.